Opioid addiction causes high degree of morbidity and mortality. Preemptive 1 identification of patients at risk of opioid dependence and developing intelligent clinical 2 decisions to deprescribe opioids to the vulnerable patient population may help in 3 reducing the burden. Identifying patients susceptible to mortality due to opioid-induced 4 side effects and understanding the landscape of drug-drug interaction pairs aggravating 5 opioid usage are significant, yet, unexplored research questions. In this study, we 6 present a collection of predictive models to identify patients at risk of opioid abuse, 7 mortality and drug-drug interactions in the context of opioid usage. Using publicly 8 available dataset from MIMIC-III, we developed predictive models (opioid abuse models 9 a=Logistic Regression; b=Extreme Gradient Boosting and mortality model= Extreme 10 Gradient Boosting) and identified potential drug-drug interaction patterns. To enable 11 the translational value of our work, the predictive model and all associated software 12 code is provided. This repository could be used to build clinical decision aids and thus 13 improve the optimization of prescription rates for vulnerable population. 14 Introduction 15 Drug overdose is the leading cause of accidental deaths in the US with 52,404 lethal 16 drug overdoses in 2015. Opioid addiction is driving this epidemic with 20,101 overdose 17 deaths related to prescription pain relievers and 12,990 overdose deaths related to heroin 18 in 2015. The overdose death rate in 2008 was nearly four times that in 1999 and the 19 sales of prescription pain relievers in 2010 were four times those in 1999 ( [1]-[2]
algorithms. In addition to this, we've explored the interactions between opioids and 28 other drugs that could result in increased incidence of a particular side effect. In order 29 to discover the relation between the interactions and the incidence of side effects we've 30 performed K-Means clustering. As aptly described in Khader et al., ( [10] ), this study 31 combines the robustness of both statistical analysis and machine learning techniques. It 32 also exemplifies the utility of publicly available biomedical datasets and its application 33 for improving public health as emphasized by Khader et al., ( [9] ).
35
Even after being acknowledged as one of the major issues, opioid epidemic remains 36 eclipsed from the artificial intelligence communities in healthcare. Che et al., ( [4] ) is 37 one of the very few attempts done to classify subjects based on opioid usage. This study 38 categorizes subjects into three groups (short term, long term and opioid dependent 39 users) based on the number of prescriptions given. Here, opioid dependent users refer to 40 those who are diagnosed with "opioid dependence". This study describes two 41 classification tasks: a) whether a short term user will turn into a long term user and b) 42 whether a long term user is an opioid dependent user. One issue with such a type of 43 classification is that the study is ignoring the possibility of a short term user developing 44 the symptoms of opioid dependence. When a subject is prescribed opioids only a few 45 times but with high dosages the subject could still be prone to adverse effects. Another 46 point to be noted in this study is that the best performing model for identifying opioid 47 dependent users is a deep learning model that uses Recurrent Neural Network (RNN).
48
As highlighted by Dudley et al., ( [8] ), it is a well-established fact that deep learning 49 models need to be trained on large datasets for better performances. However, as the 50 number of subjects who experienced opioid dependence symptoms in Che et al., ( [4] ) 51 was only 749, this study has randomly generated 14 datasets by downsampling 52 non-opioid-dependent subjects which formed two-thirds of the dataset and then trained 53 the RNN model. This might not be the most technically robust way to generate data.
54
Even with such a random generation the accuracy of the model is found to be 76.07% 55 with a recall of only 52.05%. That means, the chances of identifying a long term subject 56 who could be prone to opioid dependence using this model is better than tossing a fair 57 coin by a mere margin of 2%.
59
Also, as Dudley et al., ( [8] ) pointed out, deep learning models are often regarded as 60 models lacking interpretability in healthcare. To overcome all these issues, our study 61 advocates the use of traditional machine learning models to achieve better classification 62 accuracies by extracting data in a more robust way.
63

Materials and Methods
64
Dataset:
65
The MIMIC-III dataset consists of details of 46,520 subjects at the Beth Israel 66 Deaconess Medical Center, Boston, Massachusetts. Among these, 29,959 subjects were 67 identified with prescriptions of opioids such as Morphine, Meperidine, Codeine, In order to identify subjects with side effects, we've checked the diagnoses reports of 80 every subject prescribed with opioids for symptoms related to overdose and/or 81 dependence using the International Classification of Diseases, Ninth Revision (ICD 9) 82 codes. A few of the ICD 9 codes and categories are listed in Table 2 . A total of only 749 83 subjects were identified to have side effects. Table 2 and 0 otherwise. The gender of a subject is represented by a 89 binary variable -0 for female and 1 for male. For subjects with one or more Naloxone 90 prescriptions, the ANTI NARCOTIC flag is set to 1 and for those with prescriptions of 91 all other opioids under study, the NARCOTIC flag is set to 1. Every opioid is allocated 92 a discrete variable to represent the total number of prescriptions of that particular 93 opioid given to each subject. In addition, the total number of anti-narcotic (Naloxone) 94 and narcotic (opioids excluding Naloxone) prescriptions are also represented by two 95 discrete variables. If a subject has stayed in Intensive Care unit (ICU) then the binary 96 flag, ICU, is set to 1 and 0 otherwise. The mortality status of the subject is indicated by 97 3/12
84
another binary variable, EXPIRE FLAG. It is triggered if the subject is no more. Also, 98 the age group of every subject is represented using one-hot encoding. Finally, feature 99 normalization was done by performing an affine transformation on each feature so that 100 all the values in the dataset are in the range of [0,1]. Figure 1 shows the correlation of 101 features. It can be observed that the target variable, SIDE EFFECTS FLAG, has the 102 highest positive correlation with TOTAL ANTI NARCOTIC PRESCRIPTIONS and Dealing with class imbalance:
109
It can be observed from Table 1 that there is a huge imbalance between subjects with 110 side effects and those with no side effects. Running a classification algorithm on such a 111 data would result in overfitting the model and hence it will learn to predict the majority 112 class. As a result, the classification accuracy might be high even when the number of 113 true positives for subjects with triggered SIDE EFFECTS FLAG is terribly low. We've 114 taken two steps to address this problem. dataset in a statistically robust way but also minimized the imbalance in the dataset.
129
Addressing the issue of sparse features:
130
As described earlier, quite a number of features were based on the opioids given to the 131 subjects. A few opioids like Morphine were prescribed very often while the other opioids 132 such as Oxymorphone were rarely prescribed. As every subject had features related to 133 every opioid, the less frequently prescribed opioids led to sparse features. In order to Logistic Regression model with L2 penalty of 0.001 was run on the dataset before and 146 after performing SMOTE and PCA. The mean AUC of 10 fold cross validation can be 147 observed in Figure 3 . As it is practical and obvious that we would like to use this model to assess patients 155 who are alive, it makes more sense to drop the EXPIRE FLAG feature and look at the 156 performance of the model. By keeping all the data extraction and processing 157 methodologies same, the mean AUC with XGBoost has been found to be the same as 
Mortality as the target variable:
161 Until now we've tried predicting if a subject will show side effects when prescribed 162 opioids. But a far more fatal consequence associated with opioids is death. Being able 163 to segregate subjects with high risk of mortality could be a huge problem in itself.
164
Hence, to facilitate such a precocious identification we've run a classification algorithm 165 on the cohort that has experienced side effects. XGBoost model was trained on 80% of 166 these subjects (n=587) and tested on the remaining 20% (n=147). The accuracy of the 167 model is given in the Table 4 .
168
Interactions between opioids and other drugs:
169
This part of the study aims at discovering the interactions between opioids and other 170 drugs that could lead to potential side effects in subjects. In order to carry out this 171 study, we've considered the cohort of 749 subjects who were diagnosed with side effects 172 in the previous study (including all age groups). These subjects were given at least one 173 of the 11 opioids under consideration and 3710 other drugs put together. We've 174 7/12 categorized the side effects into 7 groups and the summary is provided in Supplementary 175 Table 1 . All the opioids were assigned an index between 1 to 11 and similarly the other 176 drugs were also indexed. For every opioid and other drug combination, the number of 177 subjects who were diagnosed with side effects in each of the above 7 groups has been 178 kept track of. These numbers were normalized before performing K-means clustering.
179
From the elbow plot shown in Figure 6 , the number of optimal clusters were found to be 180 4. Apart from the variants of regular salts like potassium chloride and sodium chloride, 181 insulin is one important drug that has been classified into the predominant cluster. As discussed earlier, we've implemented two models for classifying subjects who could, 190 possibly, be prone to adverse events upon opioid consumption. Table 4 shows that
191
XGBoost has outperformed the Logic Regression model. This could be due to the fact 192 every subject is associated with only a few opioids and hence only a subset of features 193 which are related to those particular opioids are more important than the others. And 194 since XGBoost works by sub-sampling the features, the classification accuracy of 195 enhanced model is much higher than that of the baseline. From Figure 7 , it can be
observed that XGBoost has classified the number of prescriptions associated with 197 MEPERIDINE as the most important feature in deciding the subject's susceptibility to 198 adverse events and it's followed by TOTAL NARCOTIC PRESCRIPTIONS and 199 GENDER. A more obvious result, that follows our analysis of feature correlation, is that 200 NALOXONE and MORPHINE are also among the important contributing features. Figure 7 . Importance of features.
201
Also, as desired, the XGBoost model was more sensitive in classifying subjects with 202 adverse events than those with no adverse events. Hence, the number of true positives 203 for label 1 are more than those for label 0 (Figure 8) . In other words, the model gave a 204 better recall score. Just like the previous model, it can be seen from Table 4 that the model used for 207 classifying subjects with high risk of mortality also has a higher recall score. This 208 implies that the model is able to classify subjects of concern with higher sensitivity. 209 
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Interactions between opioids and other drugs:
210
As stated earlier, insulin has been found to be in the predominant cluster associated 211 with all categories of side effects. Not only that insulin has been used widely in subjects 212 prescribed with opioids but also the incidence of side effects has been comparatively 213 huge in the case of opioid and insulin combination. This observation backs up the 214 results from two earlier studies conducted by Li et al., ( [7] ) and Sharma et al., ( [11] ) 215 The first study states that morphine could lead to desensitization of insulin receptor 216 signaling. This could've been one reason of increased usage of insulin in subjects 217 prescribed with opioids. From the second study it can be learnt that islet cells, which 218 are responsible for the production of insulin, do not respond in an appropriate manner 219 to the glucose signals in subjects with opioid addiction.
220
Discussion
221
Though the total number of subjects experiencing opioid dependence and/or adverse 222 effects in this study is same as that in Che et al., ( [4] ) results show that the current 223 models classify the subjects with a better accuracy and recall by just using traditional 224 machine learning models. Also, our enhanced model (93.26%) has outperformed the 225 RNN model (76.07%) in Che et al., ( [4] ) and can classify all subjects irrespective of the 226 number of prescriptions given to them.
227
Limitations of the current study:
228
Having said all the above, like with any other study, there are a few drawbacks 229 associated with this study as well. The model for predicting the mortality, unlike those 230 for predicting the side effects, might not be robust. This is due to the fact that the 231 reason for death of the subject remains undisclosed. Though the subject has 232 experienced side effects, his/her death might not, necessarily, be related to opioids. This 233 analysis of mortality prediction should be considered as a preliminary one. Further, the 234 study of interactions between opioids and other drugs is based solely on the frequency of 235 prescription and the frequency of incidence of side effects. As we wanted to study the 236 correlation between the incidence of side effects and the prescription opioids/drugs, Opioids are a class of drugs that are known for their use as pain relievers. They bind 242 themselves to opioid receptors on nerve cells in the brain and the nervous system to 243 mitigate pain. Addiction is one of the chronic and primary adverse events of prolonged 244 usage of opioids. They may also cause psychological disorders, muscle pain, depression, 245 anxiety attacks, etc. This study is intended to assist and double check the decisions 246 taken regarding the prescription of opioids. It aims at building a predictive model to 247 classify the subjects of interest into two categories based on their susceptibility to opioid 248 abuse. We've trained two classification models, Logistic Regression with L2 249 regularization (baseline) and Extreme Gradient Boosting (enhanced model), to achieve 250 this task. Results suggest that the enhanced model provides a promising approach to 251 identify subjects who are most vulnerable to adverse events when given opioids. If 252 employed as a reassurance technique, this study could be of tremendous help to medical 253 10/12 practitioners in designing an appropriate action plan for their subjects before 254 prescribing them opioids and will help combat the opioid epidemic.
255
Supplementary Material
256
The code supporting this study is present in a private repository on Github. Please 257 contact the corresponding authors for access. Also, the supplementary material can be 258 referred from the same repository.
